New stock news | Wego Pharmaceutical's Hong Kong IPO prospectus has become invalid.

Zhtng Cijng APP learned that the Hong Kong IPO prospectus submitted by Weijian International Holdings Group Limited (referred to as Weijian Pharmaceuticals) on November 7, 2025 expired on May 7, 2026, after being valid for 6 months, with Huatai International as its exclusive sponsor at the time of submission.